Impact of Prior Influenza and Pneumoccocal Vaccines on Humoral and Cellular Response to SARS-CoV-2 BNT162b2 Vaccination

Vaccination against SARS-CoV-2 is considered the most effective method of prevention to contain the pandemic. While highly effective SARS-CoV-2 vaccines are being applied on a large-scale, whether and to what extent the strength of the vaccine-induced immune response could be further potentiated is...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Vaccines (Basel)
Główni autorzy: Puro, Vincenzo, Castilletti, Concetta, Agrati, Chiara, Goletti, Delia, Leone, Sara, Agresta, Alessandro, Cimini, Eleonora, Tartaglia, Eleonora, Casetti, Rita, Colavita, Francesca, Meschi, Silvia, Matusali, Giulia, Lapa, Daniele, Najafi Fard, Saeid, Aiello, Alessandra, Farrone, Chiara, Gallì, Paola, Capobianchi, Maria Rosaria, Ippolito, Giuseppe
Format: Artigo
Język:Inglês
Wydane: MDPI 2021
Hasła przedmiotowe:
Brief Report
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8229609/
https://ncbi.nlm.nih.gov/pubmed/34201065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9060615
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy